By: Phalguni Deswal
The study will evaluate the company’s Gen-3 Halo headset as an at-home treatment for mild traumatic brain injury.
Phalguni Deswal is a journalist who specializes in the medical and pharmaceutical industries. With a focus on medical devices, clinical trials, and pharmaceutical advancements, Phalguni's articles provide insights into the latest developments in the healthcare sector. With contributions to publications such as Medical Device Network, Pharmaceutical-Technology, and Clinical Trials Arena, Phalguni keeps readers informed about the latest advancements and breakthroughs in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Phalguni Deswal's coverage is heavily focused on the Healthcare & Pharmaceutical industry, particularly around announcements and data citations related to neurology, MedTech, pharmaceuticals, clinical trials, and healthcare technology. Given this focus, she would likely be most responsive to pitches that offer in-depth insights into groundbreaking developments within these areas.
She seems receptive to detailed data-driven analysis and may also welcome commentary from experts who can provide valuable context or industry-specific knowledge. Pitches offering unique perspectives on acquisitions, FDA reviews of medications or medical devices could align well with her coverage.
Since there is no specified geographic focus for Phalguni's work, it suggests a global perspective on healthcare and pharmaceutical topics may be relevant when reaching out to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .